# Guiwang Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guiwang-biology

- Industry: Agribusiness
- Headquarters: Zunyi, China
- Website: www.guiwangbio.com
- Latest round: Series A (Nov 11, 2025)
- Investors on record: 1

## About

Based in Zunyi, China and founded in 2016, Guizhou Guiwang Biotechnology Co., Ltd., trading as Guiwang Biology, is a company with a complete edible fungi industry chain, integrating edible fungi strain research and development, planting, sales, edible fungi raw materials, and bio-organic fertilizer processing, and is committed to the industrialized cultivation of edible fungi. In November 2025, Guiwang Biology closed a Series A funding from new investor New Supply and Marketing Capital.
The company specializes in the cultivation and distribution of high-quality edible fungi, primarily focusing on three main products: Pleurotus eryngii (king oyster mushrooms), Cordyceps militaris (Cordyceps flowers), and Ganoderma lucidum (deer antler mushrooms). 
The company generates revenue through direct sales to retailers as well as bulk orders from industrial clients, who utilize the mushrooms in their food products. 
The funding raised in November 2025 will drive the company's continuous innovation in edible fungi technology research and development and industrial scaling, injecting new momentum into the development of modern agriculture.

## Funding rounds

- Series A, Nov 11, 2025 — New Supply and Marketing Capital

## Investors

- New Supply and Marketing Capital (https://capitalatlas.ai/funds/new-supply-and-marketing-capital) — Series A